Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
Previous close
$11.54
−$0.98 · -7.83%
Regular session · ET · Market data may be delayed.
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
Day range
Current $11.54
52-week range
Current $11.54
Regular session · ET · Market data may be delayed.
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
Day range
Current $11.54
52-week range
Current $11.54
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI10.81M0.00%689.3B USD0.03%$340.02-3.52%
iShares Russell 2000 ETFIWM8.7M0.01%71.54B USD0.19%$256.61-2.88%
Vanguard Extended Market ETFVXF4.25M0.00%30.2B USD0.05%$211.44-3.21%
Vanguard Russell 2000 ETFVTWO2.35M0.01%16.8B USD0.06%$103.76-2.76%
iShares Russell 2000 Growth ETFIWO2M0.02%12.73B USD0.24%$320.43-3.57%
Schwab U.S. Small-Cap ETFSCHA1.67M0.01%20.45B USD0.03%$30.51-2.83%
iShares Russell 2000 Value ETFIWN1.17M0.01%13.05B USD0.24%$198.84-2.08%
Fidelity Nasdaq Composite Index ETFONEQ267.23K—10.45B USD0.21%$89.52-4.94%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Vanguard Russell 2000 ETFVTWO
iShares Russell 2000 Growth ETFIWO
Schwab U.S. Small-Cap ETFSCHA
iShares Russell 2000 Value ETFIWN
Fidelity Nasdaq Composite Index ETFONEQAI-generated and delayed market data for informational and educational purposes only. Not investment advice.